Healing Realty Trust (HRT), a self-managed real estate investment company focused on purchasing healthcare-related real estate assets dedicated to serving the mental, behavioral, and physical health sectors, has entered into three new Preferred Real Estate Partnership Agreements.
HRT’s new partners are NeuroSpa, a Florida-based mental healthcare provider combining traditional and state-of-the-art treatments including ketamine infusion, Spravato and TMS; Cambridge Biotherapies, a Massachusetts-based provider of patient-focused treatments for mood and anxiety disorders using ketamine infusion, Spravato, TMS, medication management, and Ketamine-assisted Psychotherapy; and Cathexis, an Arizona-based provider of individual, family, and group outpatient therapy services.
The announcement follows HRT’s recent closing the first tranche of its $25 million Series A funding round and its acquisitions of three operating healthcare facilities in Texas, Ohio and Connecticut.
“As Americans become more interested in innovative therapy treatments and demand for new medications increases, we are proud to partner with NeuroSpa, Cambridge Biotherapies and Cathexis to expand patient access in Florida, Massachusetts and Arizona,” said Joe Caltabiano, CEO of Jupiter, Florida-based HRT. “Our team’s commitment to making a positive difference alongside mission-aligned businesses is revolutionizing the conventional real estate investment space, facilitating the administration of today’s critical health services, and laying the groundwork for tomorrow’s medicine.”
;
